Seth Alpna has filed 9 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 3777 shares of BIO-TECHNE Corp ($TECH) on October 30, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 30, 2025 | BIO-TECHNE Corp | $TECH | Seth Alpna | Director | A | Stock Options (Right to Buy) | 3777 | $0.00 | 31,289.0000 | 156,362,000 | 13.73% | 0.00% |
| Oct. 30, 2025 | BIO-TECHNE Corp | $TECH | Seth Alpna | Director | A | Common Stock | 1640 | $0.00 | 15,411.0000 | 156,362,000 | 11.91% | 0.00% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | Seth Alpna | Not found | A | Common Stock | 5250 | $0.00 | 5,250.0000 | 37,437,652 | 9999.99% | 0.01% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | Seth Alpna | Not found | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 37,437,652 | 9999.99% | 0.03% |
| Oct. 24, 2024 | BIO-TECHNE Corp | $TECH | Seth Alpna | Director | A | Stock Options (Right to Buy) | 3511 | $0.00 | 27,512.0000 | 161,115,000 | 14.63% | 0.00% |
| Oct. 24, 2024 | BIO-TECHNE Corp | $TECH | Seth Alpna | Director | A | Common Stock | 1462 | $0.00 | 13,771.0000 | 161,115,000 | 11.88% | 0.00% |
| May 30, 2024 | Keros Therapeutics, Inc. | $KROS | Seth Alpna | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 29,447,119 | 9999.99% | 0.03% |
| June 6, 2023 | Keros Therapeutics, Inc. | $KROS | Seth Alpna | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 25,241,030 | 9999.99% | 0.04% |
| May 1, 2023 | Keros Therapeutics, Inc. | $KROS | Seth Alpna | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 25,241,030 | 9999.99% | 0.08% |